SecBot SecBot
144 ·Filed Nov 2, 2026

REGN

REGENERON PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizondays Processed14d 7h ago SEC0001969223-26-001114
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing signals an officer's intent to sell a relatively small portion of holdings. Given the modest size relative to market cap and the insider's routine option exercise, this is unlikely to indicate a material change in company outlook. Monitor for actual sale execution on Form 4.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$973.36
T+0 close · Nov 2, 2026 · via day close
Latest settled
−5.89%
T+5 · $916.06 · next T+20 in 15d
Vs SPY
−5.30%
α at T+5
Latest observation
−1.37%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $973.36entry
  2. T+1 · 13d ago −4.39%α −6.04% · $930.67
  3. T+5 · 7d ago −5.89%α −5.30% · $916.06
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Joseph LaRosa, an officer of Regeneron Pharmaceuticals, filed a Form 144 notice of intent to sell 4,466 shares of common stock with an approximate market value of $4.3 million, based on a filing date of November 2, 2026. The shares were acquired via stock option exercise on January 3, 2024, and the sale is planned for execution on or after November 2, 2026.

Key Facts

  • Joseph LaRosa (Officer) filed Form 144 to sell 4,466 shares of Regeneron common stock.
  • Estimated market value of proposed sale: $4,311,875.12.
  • Shares were acquired via stock option exercise on January 3, 2024.
  • Proposed sale date: November 2, 2026.
  • Broker: UBS Financial Services Inc.
  • Regeneron market cap: $84.3 billion; proposed sale represents ~0.005% of market cap.

Financial Impact

Proposed sale of $4.3 million in shares, representing approximately 0.005% of Regeneron's $84.3 billion market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the sale may not be executed.
  • Insider selling could be perceived negatively if followed by additional filings from other officers.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
72% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001969223-26-001114
Document: 0001969223-26-001114-index.html0001969223-26-001114
Document: 0001969223-26-001114.txt0001969223-26-001114

Track record

53 reports on REGN

Performance horizon

11 of 17 bullish or bearish reports moved the stock their way by T+20. Best: +31.76% at T+20 after the Oct 6, 2026 report. 17 of 21 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $951.23 Now $952.40 +0.12% settles Dec 16
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $948.00 Now $952.40 +0.46% settles Dec 16
  3. Nov 12, 20264d ago Press Release Bullish 5/10 Entry $955.47 Now $952.40 −0.32% settles Dec 14
  4. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  5. Nov 5, 202611d ago Insider Cluster Neutral 3/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  6. Nov 4, 202612d ago 144 Neutral 1/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  7. Nov 4, 202612d ago 144 Neutral 2/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  8. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  9. Nov 3, 202613d ago 144 Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  10. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (10h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026